Related Experiment Video

Updated: May 26, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

[Research advances on treatment of hepatitis C infection based on RNA interference and microRNA modulation]

Yan-ning Liu1, Guo-hua Lou, Zhi Chen

  • 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.

Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences
|December 23, 2011
PubMed

Insights

Hepatitis C virus (HCV) infection affects 170 million globally, risking liver disease. RNA interference (RNAi) and microRNA (miRNA) offer promising gene therapy strategies for HCV treatment and prevention.

Area of Science:

  • Virology and Immunology
  • Gene Therapy and Molecular Biology

Context:

  • Hepatitis C virus (HCV) infection is a significant global health issue, impacting approximately 170 million individuals worldwide.
  • Chronic HCV infection leads to severe liver conditions, including cirrhosis, hepatocellular carcinoma (HCC), and liver failure.
  • Current prevention methods, such as vaccines and antibodies, are lacking for HCV.

Purpose:

  • To provide a comprehensive overview of RNA interference (RNAi) and microRNA (miRNA)-based strategies for treating hepatitis C infection.
  • To discuss the latest developments in therapeutic targets for RNAi against HCV.
  • To explore advancements in liver-targeted delivery systems and the role of miRNAs in HCV treatment.

Summary:

  • RNA interference (RNAi) is emerging as a potent therapeutic approach for viral infections, including HCV.
  • Progress in gene therapy has enhanced the feasibility of clinical applications for RNAi-based treatments.
  • RNAi research has identified numerous viral and host-cell factors as potential therapeutic targets for HCV.

Impact:

  • RNAi and miRNA-based antiviral strategies hold significant promise for the future treatment of hepatitis C.
  • Advances in gene delivery techniques are crucial for the successful clinical application of these therapies.
  • Understanding the critical role of microRNAs in HCV infection opens new avenues for antiviral drug development.

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

MicroRNA-based Regulation of Picornavirus Tropism09:05

MicroRNA-based Regulation of Picornavirus Tropism

Published on: February 6, 2017

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...